Medicis

236 articles about Medicis

• $20 Million Class Action Settlement has been Reached for Purchasers of Solodyn®

  4/30/2018

  A proposed $20 million settlement has been reached in a class action lawsuit involving the antibiotic drug Solodyn®.

• Medicis Announces Winners of First Annual I Acanya&#0174 Succeed Scholarship Program to Help Students Follow their Dreams

  9/27/2013

• Valeant Pharmaceuticals International to Shutter Medicis Ops in AZ

  7/31/2013

• Medicis CEO Girlfriend Was Murdered: Lawsuit

  7/15/2013

• At Least 200 Former Medicis Employees Laid Off After Aquisition

  12/18/2012

• Valeant Pharmaceuticals International Completes Acquisition of Medicis and Announces Date of 2013 Financial Guidance Conference Call

  12/11/2012

• Valeant Pharmaceuticals International Receives Federal Trade Commission Clearance for Medicis Acquisition

  11/16/2012

• ReVance Therapeutics, Inc. Settles With Medicis for Up to $25 Million, Regains Global Rights to Botulinum Toxin Products

  10/8/2012

• Valeant Pharmaceuticals International Continues Aggressive Strategy With $2.6 Billion Medicis Buy

  9/27/2012

• Medicis Declares Cash Dividend

  9/21/2012

• Layoffs Expected at Medicis After the Sale

  9/5/2012

• Medicis' Skin Drug Gets Generic Threat From Actavis Mid Atlantic

  8/16/2012

• Medicis Reports Second Quarter 2012 Financial Results

  8/9/2012

• Medicis Announces 2012 Second Quarter Conference Call and Webcast

  8/6/2012

• Medicis Declares Cash Dividend

  6/14/2012

• Medicis to Present at Goldman, Sachs & Co. Global Healthcare Conference

  6/4/2012

• Medicis to Present at Bank of America Merrill Lynch 2012 Health Care Conference

  5/14/2012

• Medicis Announces Pricing of $450 Million of Convertible Notes

  5/11/2012

• Medicis Announces Offering of $400 Million of Convertible Notes

  5/10/2012

• Medicis Reports First Quarter 2012 Financial Results

  5/9/2012